The Coalition is always on the lookout for changes in policy and current events that could impact the health status of LGBTQ+ individuals, or influence access to and utilization of health care within the LGBTQ+ community. These Advocacy Briefs summarize recent news items, along with specific action steps you can take to advocate for LGBTQ+ health equity.
Comments on the Oregon Prescription Drug Affordability Board’s affordability review of Odefsey.
HealthHIV and the National Coalition for LGBTQ Health welcome today’s Supreme Court decision in Kennedy v. Braidwood Management, Inc, which upholds the federal government’s prior position; and affirms the authority of the U.S. Preventive Services Task Force (USPSTF) in guiding coverage requirements under the Patient Protection and Affordable Care Act (ACA).
Since taking office in January 2025, President Trump has taken a series of actions that remove or weaken health protections for LGBTQ+ people. These actions collectively aim to restrict recognition of gender identity, limit access to gender-affirming care, dismantle diversity and equity programs, and reshape federal funding criteria—directly affecting the health, access, and rights of…
Co-signed letter to the leadership of the US Senate regarding the introduced Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act.
Comments on proposed formulary changes to Oregon’s Medicaid program to the Oregon Health Authority.
Comments on proposed revisions to the Older Americans Act in the context of Section 504 of the Rehabilitation Act and concerns regarding quality-adjusted life-years (QALYs).
Comments on proposed revisions to the Older Americans Act regarding LGBTQI+ community and other considerations.
Advancements in treatment for HIV have enabled PLWH to live long lives and by 2030, an estimated 70% of PLWH will be 50 years or older. Unfortunately, there have been many cases where PLWH develop cognitive impairments because of accelerated normal aging.
The CDC recommends sharing information about all the Hepatitis treatment and therapeutic options that are already widely available. They’re also asking the public to promote the CDC’s adult vaccine assessment tool, which recommends vaccines based on age, health, and occupation.
Along the lines of expanding access to (and better utilization of) routine care and prevention services, the Oregon State Legislature is poised to pass a bill that allows registered pharmacists to prescribe HIV pre-and post-exposure prophylaxis (PrEP and PEP) drugs.
In Washington state, a collective sense of relief was felt when the session’s final gavel came down on April 30th.